<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Anticardiolipin antibodies (aCL) were recently discovered to recognize a complex consisting of <z:chebi fb="1" ids="16247">phospholipids</z:chebi> and <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> H (apo H) </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we determined the serum apo H levels in 36 <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) patients with or without <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL), including aCL and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi>, to clarify the possible effects of aPL on apo H levels in vivo </plain></SENT>
<SENT sid="2" pm="."><plain>The apo H levels were low in SLE patients as compared with 22 healthy controls </plain></SENT>
<SENT sid="3" pm="."><plain>However, no associations were found between apo H levels and circulating aPL or clinical features of the <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome </plain></SENT>
<SENT sid="4" pm="."><plain>A secondary hyperlipidemic state, which probably related to <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> (<z:hpo ids='HP_0000093'>proteinuria</z:hpo>) and/or <z:chebi fb="2" ids="8378">prednisolone</z:chebi> treatment, increased apo H levels in SLE patients </plain></SENT>
</text></document>